Checkpoint Therapeutics, Inc. (CKPT)

Checkpoint Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-51.85	-62.62	-56.67	-23.08	-24.71
Share-Based Compensation	2.9	2.92	3.14	2.78	3.12
Other Operating Activities	1.36	2.15	27.23	3.75	0.22
Operating Cash Flow	-47.59	-57.55	-26.31	-16.55	-21.37
Share Issuance / Repurchase	30.33	14.89	40.27	33.28	27.57
Other Financing Activities	10.12	-	-	-2.03	-2.12
Financing Cash Flow	40.45	14.89	40.27	31.25	25.46
Net Cash Flow	-7.14	-42.67	13.96	14.7	4.08
Free Cash Flow	-47.59	-57.55	-26.31	-16.55	-21.37
Free Cash Flow Margin	-46203.88%	-29976.04%	-9815.67%	-1548.27%	-1251.35%
Free Cash Flow Per Share	-2.54	-6.51	-3.46	-2.96	-6.05

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).